TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27716215

Group type: EXPERIMENTAL
Intervention: Kinematic real-time feedback (KRTF) group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional method group (G1)
Number of subjects: 0
Study: 24252058

Group type: EXPERIMENTAL
Intervention: BAY 79-4980 (35 IU kg(‐1))
Number of subjects: 131

Group type: COMPARATOR
Intervention: rFVIII-FS (25 IU kg(‐1))
Number of subjects: 131
Study: 21517925

Group type: EXPERIMENTAL
Intervention: Mitiglinide 5 mg (fasted)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mitiglinide 10 mg (fasted)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Mitiglinide 20 mg (fasted)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mitiglinide (all doses)
Number of subjects: 24
Study: 21057743

Group type: EXPERIMENTAL
Intervention: Barrier-strengthening moisturizer (5% urea)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No treatment (no medical or non-medicated preparations)
Number of subjects: 53
Study: 17951496

Group type: EXPERIMENTAL
Intervention: 8 g/d of Synergy (inulin-type fructans)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Maltodextrin control
Number of subjects: 48
Study: 15699296

Group type: EXPERIMENTAL
Intervention: Venlafaxine ER (75‐225 mg/d)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Paroxetine (20‐50 mg/d)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 12050266

Group type: EXPERIMENTAL
Intervention: Flutamide (250 mg, n = 10)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Metformin (1275 mg, n = 8)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combined therapy (Flutamide + Metformin, n = 13)
Number of subjects: 31
Study: 10471871

Group type: EXPERIMENTAL
Intervention: Clindamycin (Cleocin)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanate (Augmentin) and ticarcillin/clavulanate (Timentin)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 8543489

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 81

Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 81
Study: 2043514

Group type: EXPERIMENTAL
Intervention: Ultrasound guided percutaneous aspiration and lavage of the gallbladder followed by intra‐lumenal instillation of 500 mg ampicillin (PALA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional treatment with 500 mg of ampicillin every 6 hours for 5 days (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PALA
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 6458250

Group type: EXPERIMENTAL
Intervention: Corsets with lumbar supports
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corsets without lumbar supports
Number of subjects: 0
Study: 31840204

Group type: EXPERIMENTAL
Intervention: Tanzo Cu‐NiTi archwire
Number of subjects: 50

Group type: COMPARATOR
Intervention: NT3 superelastic NiTi archwire
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both archwires
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 0.014-in. archwire
Number of subjects: 50
Study: 28833074

Group type: EXPERIMENTAL
Intervention: BMI ≥ 35 kg/m2
Number of subjects: 151996
Study: 27644162

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) treatment for a minimum of 1 month
Number of subjects: 53

Group type: COMPARATOR
Intervention: Isocapnic-hypoxia
Number of subjects: 53

Group type: COMPARATOR
Intervention: Normoxia
Number of subjects: 53
Study: 24797207

Group type: EXPERIMENTAL
Intervention: Pulses (chickpeas, yellow peas, navy beans, lentils)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lentils
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chickpeas
Number of subjects: 0
Study: 21820829

Group type: EXPERIMENTAL
Intervention: Dose-modulated ECG-gated CT angiography
Number of subjects: 60
Study: 19236986

Group type: EXPERIMENTAL
Intervention: Spontaneous strategy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Symmetric strategy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Asymmetric-2 strategy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Asymmetric-1 strategy
Number of subjects: 12
Study: 17306974

Group type: EXPERIMENTAL
Intervention: CEF (cyclophosphamide, epirubicin, and fluorouracil)
Number of subjects: 1224

Group type: COMPARATOR
Intervention: CMF (cyclophosphamide, methotrexate, and fluorouracil)
Number of subjects: 1224
Study: 15094937

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 73
Study: 12377352

Group type: EXPERIMENTAL
Intervention: 192Ir multiple seed trains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dose-volume histograms (DVH) for an eccentric seed train
Number of subjects: 0
Study: 9848300

Group type: EXPERIMENTAL
Intervention: Raloxifene 150 mg/d
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogen (CEE) 0.625 mg/d
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 7926342

Group type: EXPERIMENTAL
Intervention: Continuous insulin infusion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Multiple injections (4‐6 times daily)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional treatment (twice daily)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 45
Study: 2573264

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg daily (AT 50)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily (AT 100)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg twice a day (Prop)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 173257

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (5,500 RHD CO‐60)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Primary operation (no preoperative irradiation)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 196

Group type: COMPARATOR
Intervention: Primary operation
Number of subjects: 196
Study: 31559845

Group type: EXPERIMENTAL
Intervention: 15-channel phased array head coil
Number of subjects: 300

Group type: COMPARATOR
Intervention: 6-channel dS Flex M surface coil
Number of subjects: 300
Study: 31409636

Group type: EXPERIMENTAL
Intervention: GAM (gamification-based training)
Number of subjects: 489

Group type: COMPARATOR
Intervention: EVA (evaluation-based training)
Number of subjects: 489

Group type: COMPARATOR
Intervention: VFC (visual feedback complementary training)
Number of subjects: 489

Group type: COMPARATOR
Intervention: TC (traditional complementary training)
Number of subjects: 489
Study: 28228317

Group type: EXPERIMENTAL
Intervention: SAXA-MET (5 mg/2,000 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: MET (2,000 mg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: SAXA (5 mg)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: SAXA-MET
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: SAXA-MET and SAXA
Number of subjects: 38
Study: 26028918

Group type: EXPERIMENTAL
Intervention: Arbekacin
Number of subjects: 95

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 95
Study: 24074421

Group type: EXPERIMENTAL
Intervention: Proficiency-based suturing/knot-tying curriculum
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intervention MS4 vs Boot-Camp MS4
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intervention MS4 vs PGY-1 interns
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intervention MS4 vs PGY-2 residents
Number of subjects: 21
Study: 22108474

Group type: EXPERIMENTAL
Intervention: Silver Oxide Ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best management (control)
Number of subjects: 0
Study: 19370045

Group type: EXPERIMENTAL
Intervention: 16.6 g of whey protein + 3.4 g of leucine (W+L)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flavored water (PL)
Number of subjects: 0
Study: 16761701

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 15378556

Group type: EXPERIMENTAL
Intervention: 250 mg divalproex sodium extended-release (divalproex-ER)
Number of subjects: 39

Group type: COMPARATOR
Intervention: 500 mg divalproex sodium extended-release (divalproex-ER)
Number of subjects: 39
Study: 11387490

Group type: EXPERIMENTAL
Intervention: Ultrasound contrast agent (Levovist, 300 mg/mL, 1 mL/min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No ultrasound contrast agent (USCA)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Continuous infusion of USCA
Number of subjects: 26
Study: 9409267

Group type: EXPERIMENTAL
Intervention: Endothelin-1 (ET-1) administered intravenously for 6 hours
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo administered intravenously for 6 hours
Number of subjects: 12
Study: 8494374

Group type: EXPERIMENTAL
Intervention: Intensive aluminum‐magnesium hydroxide antacid regimen (Maalox TC) administered at multiple time points relative to enoxacin infusion.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous enoxacin (400 mg) administered without antacid treatment.
Number of subjects: 12
Study: 3317784

Group type: EXPERIMENTAL
Intervention: Budesonide enema, 2 mg/100 ml
Number of subjects: 64

Group type: COMPARATOR
Intervention: Prednisolone disodium phosphate enema, 31.25 mg/100 ml
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Budesonide enema
Number of subjects: 64

Group type: COMPARATOR
Intervention: Prednisolone enema
Number of subjects: 64
Study: 30429920

Group type: EXPERIMENTAL
Intervention: Left ventricular assist device (LVAD) patients presenting to the ED
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Reasons for presentation to the ED
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Device-specific presentations
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Interventions for device-specific presentations
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Pump thrombosis
Number of subjects: 349
Study: 28211882

Group type: EXPERIMENTAL
Intervention: Aflibercept (2 mg) administered as three monthly intravitreal injections followed by two bi-monthly injections and a final examination at week 28.
Number of subjects: 46
Study: 25413264

Group type: EXPERIMENTAL
Intervention: Standard care plus financial reinforcement
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Overall participants
Number of subjects: 29
Study: 23279731

Group type: EXPERIMENTAL
Intervention: Electronic questionnaire sent via e-mail at 8PM asking about SCL visual performance
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Electronic questionnaire on weekdays (Sunday through Thursday)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Electronic questionnaire on weekends (Friday and Saturday)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Participants aged 23 and older
Number of subjects: 48
Study: 21464563

Group type: EXPERIMENTAL
Intervention: Ultrasound-assisted wound treatment (UAW)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Surgical wound debridement (WD)
Number of subjects: 67
Study: 18493214

Group type: EXPERIMENTAL
Intervention: Long-chain polyunsaturated fatty acids (LCPUFAs) supplementation (AA: 20-30 mg daily, DHA: 14-21 mg daily)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 16566900

Group type: EXPERIMENTAL
Intervention: Fludrocortisone (0.5 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 15799928

Group type: EXPERIMENTAL
Intervention: Total arterial off-pump coronary artery bypass grafting (OPCAB)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Conventional on-pump coronary artery bypass grafting (CCAB)
Number of subjects: 152
Study: 11273502

Group type: EXPERIMENTAL
Intervention: Yoga lifestyle intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (conventional methods)
Number of subjects: 42
Study: 9089582

Group type: EXPERIMENTAL
Intervention: liposome-adjuvanted vaccine
Number of subjects: 77

Group type: COMPARATOR
Intervention: control subvirion vaccine
Number of subjects: 77
Study: 1337623

Group type: EXPERIMENTAL
Intervention: 400 mg lomefloxacin once daily for 3 days (L3)
Number of subjects: 703

Group type: EXPERIMENTAL
Intervention: 400 mg lomefloxacin once daily for 7 days (L7)
Number of subjects: 703

Group type: COMPARATOR
Intervention: 400 mg norfloxacin twice daily for 7 days (N7)
Number of subjects: 703
Study: 2858246

Group type: EXPERIMENTAL
Intervention: Counselling about drinking habits from a nurse
Number of subjects: 156

Group type: COMPARATOR
Intervention: Routine medical care
Number of subjects: 156
Study: 31479209

Group type: EXPERIMENTAL
Intervention: Genotype-guided group (CYP2C19 genetic testing)
Number of subjects: 2488

Group type: COMPARATOR
Intervention: Standard-treatment group (ticagrelor or prasugrel)
Number of subjects: 2488
Study: 29601443

Group type: EXPERIMENTAL
Intervention: Digital Rectal Examination (DRE)
Number of subjects: 233

Group type: COMPARATOR
Intervention: No DRE
Number of subjects: 233
Study: 27465112

Group type: COMPARATOR
Intervention: Education on routine hygiene measures
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Education plus decolonization without reminders (intranasal mupirocin ointment twice daily for 7 days and chlorhexidine gluconate on the first and last day)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Education plus decolonization with reminders (daily telephone call or text message reminders)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Compliance with decolonization protocol
Number of subjects: 223
Study: 24612260

Group type: EXPERIMENTAL
Intervention: Ketamine/ondansetron group
Number of subjects: 237

Group type: COMPARATOR
Intervention: Ketamine-only group
Number of subjects: 237
Study: 22472069

Group type: EXPERIMENTAL
Intervention: PKRP combined with 2 μm laser vaporization
Number of subjects: 120

Group type: COMPARATOR
Intervention: PKRP only
Number of subjects: 120
Study: 19726422

Group type: EXPERIMENTAL
Intervention: bimatoprost 0.03%
Number of subjects: 266

Group type: COMPARATOR
Intervention: travoprost 0.004%
Number of subjects: 266
Study: 17043094

Group type: EXPERIMENTAL
Intervention: Arm B (weekly): gemcitabine 1000 mg/m2 and paclitaxel 100 mg/m2 on days 1 and 8 of a 21-day cycle
Number of subjects: 100

Group type: COMPARATOR
Intervention: Arm A (three-weekly): gemcitabine 1000 mg/m2 on days 1 and 8 and paclitaxel 200 mg/m2 on day 1 of a 21-day cycle
Number of subjects: 100
Study: 16253098

Group type: COMPARATOR
Intervention: Full-mouth scaling and root planing (SRP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SRP and 400 mg systemically administered metronidazole (MET) three times per day for 10 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SRP and professional supragingival plaque removal (PP) every week for 3 months
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: SRP and MET plus PP
Number of subjects: 60
Study: 12411355

Group type: EXPERIMENTAL
Intervention: Free smoke alarms distributed and installed on request
Number of subjects: 20050
Study: 10640634

Group type: EXPERIMENTAL
Intervention: Static flexor and extensor thresholds
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Maximal flexor and extensor torques
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Active torque production
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Reciprocally organized agonist and antagonist muscle activity
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Excessive muscle coactivation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Spasticity measured at rest
Number of subjects: 12
Study: 8795759

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.2 mg/ml)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 28
Study: 1637268

Group type: EXPERIMENTAL
Intervention: Advancement of the capsulopalpebral head combined with inferior rectus recession
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inferior rectus recession alone
Number of subjects: 0
Study: 6432887

Group type: EXPERIMENTAL
Intervention: Acyclovir (ACV)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Trifluorothymidine (TFT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Both ACV and TFT
Number of subjects: 37
Study: 31472446

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg po bid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo bid
Number of subjects: 40
Study: 30325687

Group type: EXPERIMENTAL
Intervention: HTP (hyaluronic acid-based topical lubricant)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HA (hyaluronic acid)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NaCl (sodium chloride)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HTP
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HA
Number of subjects: 60

Group type: COMPARATOR
Intervention: NaCl
Number of subjects: 60
Study: 27282490

Group type: EXPERIMENTAL
Intervention: LQNS
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: COMPARATOR
Intervention: LQNS and Placebo
Number of subjects: 43
Study: 24575916

Group type: EXPERIMENTAL
Intervention: Video conferencing technology (VCT) for mental health data collection
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Video conferencing technology (VCT) for study assessments
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Interviewer skills
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: VCT in various settings
Number of subjects: 19
Study: 22975536

Group type: EXPERIMENTAL
Intervention: β‐blockers
Number of subjects: 28

Group type: COMPARATOR
Intervention: Methimazole + β‐blockers
Number of subjects: 28

Group type: COMPARATOR
Intervention: Methimazole without β‐blockers
Number of subjects: 28
Study: 20116081

Group type: EXPERIMENTAL
Intervention: CK‐IHC (Cytokeratin immunohistochemistry)
Number of subjects: 107

Group type: COMPARATOR
Intervention: H&E (Hematoxylin and eosin staining)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: CK‐IHC
Number of subjects: 107
Study: 18062059

Group type: EXPERIMENTAL
Intervention: 10-week cognitive-behavioral stress management (CBSM) intervention
Number of subjects: 71

Group type: COMPARATOR
Intervention: Half-day stress management seminar (control condition)
Number of subjects: 71
Study: 15857284

Group type: EXPERIMENTAL
Intervention: Brinzolamide 1% (twice a day)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dorzolamide 1% (3 times a day)
Number of subjects: 52
Study: 12461202

Group type: EXPERIMENTAL
Intervention: Rehabilitation
Number of subjects: 442

Group type: COMPARATOR
Intervention: Control
Number of subjects: 442
Study: 10614063

Group type: EXPERIMENTAL
Intervention: Glibenclamide (5 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 7626872

Group type: EXPERIMENTAL
Intervention: Normothermic temperature (37 degrees C)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Tepid temperature (34 degrees C)
Number of subjects: 200
Study: 30922259

Group type: EXPERIMENTAL
Intervention: Magnesium-zinc-calcium-vitamin D co-supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 28181941

Group type: EXPERIMENTAL
Intervention: 1.4% sodium bicarbonate
Number of subjects: 307

Group type: COMPARATOR
Intervention: 0.9% sodium chloride
Number of subjects: 307
Study: 26483224

Group type: EXPERIMENTAL
Intervention: Montelukast (4 mg once a day for 7 days)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (routine medical treatment only)
Number of subjects: 75
Study: 23596782

Group type: EXPERIMENTAL
Intervention: Shugan Jianpi Gusui Recipe (SJGR) administered during the remission phase
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group treated with azathioprine alone or no treatment
Number of subjects: 35
Study: 21331063

Group type: EXPERIMENTAL
Intervention: Insulin Resistant (IR) group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 17999153

Group type: EXPERIMENTAL
Intervention: IL-10 ‐819 TT genotype
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: IL-10 ‐592 AA genotype
Number of subjects: 584
Study: 16334719

Group type: EXPERIMENTAL
Intervention: Zishen Tongli Jiaonang (capsules for nourishing the kidney and promoting urination)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Antibiotics according to drug sensitive tests (control group)
Number of subjects: 256
Study: 12903793

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Postoperative pain
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Postoperative day
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Preoperative pulmonary function
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Surgical style
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Baseline pulmonary function
Number of subjects: 64
Study: 10369064

Group type: EXPERIMENTAL
Intervention: Residential treatment
Number of subjects: 188

Group type: COMPARATOR
Intervention: Day treatment
Number of subjects: 188
Study: 9157769

Group type: EXPERIMENTAL
Intervention: Slow-release sodium fluoride (SR-NaF)
Number of subjects: 507
Study: 1799898

Group type: EXPERIMENTAL
Intervention: NTTS 10
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NTTS 20
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ISD 40
Number of subjects: 12

Group type: COMPARATOR
Intervention: PL
Number of subjects: 12
Study: 6440446

Group type: EXPERIMENTAL
Intervention: Alfentanil (500 micrograms)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Alfentanil (250 micrograms at induction, followed by 250 micrograms prior to surgery)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Halothane (1.5%)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Methohexitone
Number of subjects: 90
Study: 30473262

Group type: EXPERIMENTAL
Intervention: Incremental video intervention (60-second video emphasizing ability improves with practice)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Entity video intervention (60-second video emphasizing ability is fixed)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Incremental article intervention (fabricated journal article emphasizing ability improves with practice)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Entity article intervention (fabricated journal article emphasizing ability is fixed)
Number of subjects: 203